Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets.

Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol (2004) 3.23

SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am J Hum Genet (2005) 2.42

Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia. J Clin Invest (2008) 1.38

Evidence for a bone-kidney axis regulating phosphate homeostasis. J Clin Invest (2003) 1.33

Fibroblast growth factor 23: state of the field and future directions. Trends Endocrinol Metab (2012) 1.21

Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): implications for disorders of phosphate metabolism. Pediatr Nephrol (2009) 1.14

PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets. Hum Genet (2009) 1.03

Correction of proximal tubule phosphate transport defect in Hyp mice in vivo and in vitro with indomethacin. Proc Natl Acad Sci U S A (2003) 1.03

Hexa-D-arginine treatment increases 7B2•PC2 activity in hyp-mouse osteoblasts and rescues the HYP phenotype. J Bone Miner Res (2013) 0.99

Hereditary disorders of renal phosphate wasting. Nat Rev Nephrol (2010) 0.98

A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells. J Bone Miner Res (2012) 0.97

Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia. Hum Mol Genet (2013) 0.96

Mutational survey of the PHEX gene in patients with X-linked hypophosphatemic rickets. Bone (2008) 0.92

An ethyl-nitrosourea-induced point mutation in phex causes exon skipping, x-linked hypophosphatemia, and rickets. Am J Pathol (2002) 0.91

The molecular background to hypophosphataemic rickets. Arch Dis Child (2000) 0.91

Expression and distribution of SIBLING proteins in the predentin/dentin and mandible of hyp mice. Oral Dis (2010) 0.90

The PHEX transgene corrects mineralization defects in 9-month-old hypophosphatemic mice. Calcif Tissue Int (2008) 0.90

Cellular ATP synthesis mediated by type III sodium-dependent phosphate transporter Pit-1 is critical to chondrogenesis. J Biol Chem (2010) 0.85

Role of prostaglandins in the pathogenesis of X-linked hypophosphatemia. Pediatr Nephrol (2006) 0.85

Fibroblast growth factor-23 increases mouse PGE2 production in vivo and in vitro. Am J Physiol Renal Physiol (2005) 0.83

Mutational analysis of PHEX, FGF23 and DMP1 in a cohort of patients with hypophosphatemic rickets. Clin Endocrinol (Oxf) (2011) 0.82

Phosphatonin washout in Hyp mice proximal tubules: evidence for posttranscriptional regulation. Am J Physiol Renal Physiol (2004) 0.82

Organization and chromosomal localization of the human ECEL1 (XCE) gene encoding a zinc metallopeptidase involved in the nervous control of respiration. Biochem J (2000) 0.81

Insights from genetic disorders of phosphate homeostasis. Semin Nephrol (2013) 0.81

Kidney and phosphate metabolism. Electrolyte Blood Press (2008) 0.78

Whole Exome Sequencing Reveals Novel PHEX Splice Site Mutations in Patients with Hypophosphatemic Rickets. PLoS One (2015) 0.75

Urinary prostaglandins and the effect of indomethacin on phosphate excretion in children with hypophosphatemic rickets. Pediatr Res (2008) 0.75

Whole exome sequencing confirms the clinical diagnosis of Marfan syndrome combined with X-linked hypophosphatemia. J Transl Med (2015) 0.75

Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice. PLoS Biol (2016) 0.75

A Mutation in the Dmp1 Gene Alters Phosphate Responsiveness in Mice. Endocrinology (2017) 0.75

ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell (1994) 2.75

Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. Proc Natl Acad Sci U S A (1976) 2.59

Common acute lymphoblastic leukemia antigen (CALLA) is active neutral endopeptidase 24.11 ("enkephalinase"): direct evidence by cDNA transfection analysis. Proc Natl Acad Sci U S A (1989) 1.67

cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone. Genomics (1996) 1.41

Mapping of human X-linked hypophosphataemic rickets by multilocus linkage analysis. Hum Genet (1986) 1.17

Molecular cloning and primary structure of Kell blood group protein. Proc Natl Acad Sci U S A (1991) 1.14

Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): multiple miniexons and separate 5' untranslated regions. Proc Natl Acad Sci U S A (1989) 1.14

Abnormal vitamin D metabolism in the X-linked hypophosphatemic mouse. Endocrinology (1980) 1.04

Bridging markers defining the map position of X linked hypophosphataemic rickets. J Med Genet (1987) 1.02

Refining the genetic map for the region flanking the X-linked hypophosphataemic rickets locus (Xp22.1-22.2). Hum Genet (1994) 1.02

Familial hypophosphatemic rickets showing autosomal dominant inheritance. Birth Defects Orig Artic Ser (1971) 0.97

Multilocus mapping of the X-linked hypophosphatemic rickets gene. J Clin Endocrinol Metab (1992) 0.92

Fine structure mapping of the human X-linked hypophosphatemic rickets gene locus. J Clin Endocrinol Metab (1994) 0.89

A YAC contig spanning the hypophosphatemic rickets disease gene (HYP) candidate region. Genomics (1994) 0.85

Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell (1987) 20.27

Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell (1987) 16.01

Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci U S A (1977) 13.87

The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell (1999) 11.59

The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell (1988) 10.75

Mutation detection and single-molecule counting using isothermal rolling-circle amplification. Nat Genet (1998) 9.84

Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature (1999) 7.73

B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med (2001) 6.97

An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics (1988) 6.51

Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature (1986) 6.45

Cloning the gene for an inherited human disorder--chronic granulomatous disease--on the basis of its chromosomal location. Nature (1986) 6.34

Revealing the maximum strength in nanotwinned copper. Science (2009) 6.27

Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Proc Natl Acad Sci U S A (1985) 5.50

Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet (1990) 5.16

The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet (1989) 5.09

Exploring the DNA-binding specificities of zinc fingers with DNA microarrays. Proc Natl Acad Sci U S A (2001) 5.08

Regional localization on the human X of DNA segments cloned from flow sorted chromosomes. Nucleic Acids Res (1982) 4.67

Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment. Nature (1985) 4.62

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron (2001) 4.42

Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13

Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature (1989) 4.08

Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science (1995) 3.66

Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell (1988) 3.57

The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo. Cell (1996) 3.55

Quantitative interpretation of magnetization transfer. Magn Reson Med (1993) 3.55

Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci U S A (2000) 3.47

A prognostic score for patients with lower risk myelodysplastic syndrome. Leukemia (2007) 3.45

Immunoelectron microscopic localization of dystrophin in myofibres. Nature (1988) 3.37

TGF-beta is a critical mediator of acute lung injury. J Clin Invest (2001) 3.29

Smoking duration, intensity, and risk of Parkinson disease. Neurology (2010) 3.19

'Seed' analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737. Oncogene (2006) 3.10

Prenatal diagnosis and carrier detection of Duchenne muscular dystrophy with closely linked RFLPs. Lancet (1985) 3.08

Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am J Hum Genet (1991) 2.79

Parallel genotyping of human SNPs using generic high-density oligonucleotide tag arrays. Genome Res (2000) 2.79

Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem (1998) 2.78

The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature (1988) 2.75

Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. J Biol Chem (1990) 2.69

The fibronectin type III domain as a scaffold for novel binding proteins. J Mol Biol (1998) 2.65

Localization and cloning of Xp21 deletion breakpoints involved in muscular dystrophy. Hum Genet (1987) 2.64

Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP. FASEB J (1999) 2.50

The structural and functional diversity of dystrophin. Nat Genet (1993) 2.43

Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus. Nature (1989) 2.43

A genome-wide scan for linkage to human exceptional longevity identifies a locus on chromosome 4. Proc Natl Acad Sci U S A (2001) 2.42

COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J (2001) 2.41

Watching the growth of bulk grains during recrystallization of deformed metals. Science (2004) 2.38

The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat Med (1997) 2.24

Molecular profiles of inflammatory myopathies. Neurology (2002) 2.21

Rapid detection of CA polymorphisms in cloned DNA: application to the 5' region of the dystrophin gene. Am J Hum Genet (1991) 2.17

Measles, mumps, and rubella (MMR) vaccine and autism. Ecological studies cannot answer main question. BMJ (2001) 2.15

Characterization of pp60c-src tyrosine kinase activities using a continuous assay: autoactivation of the enzyme is an intermolecular autophosphorylation process. Biochemistry (1995) 2.13

Dystrophin abnormalities in Duchenne/Becker muscular dystrophy. Neuron (1989) 2.13

A physical map of 4 million bp around the Duchenne muscular dystrophy gene on the human X-chromosome. Cell (1986) 2.12

Regulation of presynaptic terminal organization by C. elegans RPM-1, a putative guanine nucleotide exchanger with a RING-H2 finger domain. Neuron (2000) 2.12

Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature (1991) 2.11

Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma. Ann Oncol (2010) 2.06

Context sequences of translation initiation codon in plants. Plant Mol Biol (1997) 2.05

Dystrophin is transcribed in brain from a distant upstream promoter. Proc Natl Acad Sci U S A (1991) 2.04

A 10-megabase physical map of human Xp21, including the Duchenne muscular dystrophy gene. Genomics (1988) 2.04

Human Y-chromosome-specific reiterated DNA. Science (1976) 2.02

A general and efficient copper catalyst for the amidation of aryl halides and the N-arylation of nitrogen heterocycles. J Am Chem Soc (2001) 1.99

Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans. J Exp Med (1993) 1.94

Residue-based control of helix shape in beta-peptide oligomers. Nature (1997) 1.94

The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil (2011) 1.93

Cloning and characterization of two human skeletal muscle alpha-actinin genes located on chromosomes 1 and 11. J Biol Chem (1992) 1.91

Long-range genomic map of the Duchenne muscular dystrophy (DMD) gene: isolation and use of J66 (DXS268), a distal intragenic marker. Genomics (1987) 1.89

Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes (1996) 1.85

Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. J Neurochem (2000) 1.82

Filamin 2 (FLN2): A muscle-specific sarcoglycan interacting protein. J Cell Biol (2000) 1.82

Improved diagnosis of Becker muscular dystrophy by dystrophin testing. Neurology (1989) 1.81

Subcellular fractionation of dystrophin to the triads of skeletal muscle. Nature (1988) 1.81

Direct method for prenatal diagnosis and carrier detection in Duchenne/Becker muscular dystrophy using the entire dystrophin cDNA. Am J Med Genet (1988) 1.80

Architecture for a Web-based clinical information system that keeps the design open and the access closed. Proc AMIA Symp (1998) 1.79

Vascular endothelial growth factor as a marker of tumor endothelium. Cancer Res (1998) 1.78

Induction of type I diabetes by interferon-alpha in transgenic mice. Science (1993) 1.68

The diagnosis and treatment of dentinogenic ghost cell tumor. Int J Oral Maxillofac Surg (2009) 1.67

Conservation of the Duchenne muscular dystrophy gene in mice and humans. Science (1987) 1.66

Syntrophin binds to an alternatively spliced exon of dystrophin. J Cell Biol (1995) 1.65

Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle. Neuromuscul Disord (1991) 1.65

An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-α and cAMP/PKA pathways. Leukemia (2011) 1.61

Autosomal recessive retinitis pigmentosa caused by mutations in the alpha subunit of rod cGMP phosphodiesterase. Nat Genet (1995) 1.61

Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc Natl Acad Sci U S A (2000) 1.60

Identification of a chromosome 6-encoded dystrophin-related protein. J Biol Chem (1990) 1.60

The subcellular distribution of dystrophin in mouse skeletal, cardiac, and smooth muscle. J Cell Biol (1991) 1.59

Early and late long-term effects of vasectomy on serum testosterone, dihydrotestosterone, luteinizing hormone and follicle-stimulating hormone levels. J Urol (1995) 1.59

Dystrophies and heart disease. Curr Opin Cardiol (1997) 1.58

Primary adhalin deficiency as a cause of muscular dystrophy in patients with normal dystrophin. Ann Neurol (1995) 1.58

Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide. J Exp Med (2001) 1.57

COP9 signalosome-directed c-Jun activation/stabilization is independent of JNK. J Biol Chem (1999) 1.57

5-Azacytidine-induced reactivation of a herpes simplex thymidine kinase gene. Science (1982) 1.56

Caveolin-3 in muscular dystrophy. Hum Mol Genet (1998) 1.55

An alternative dystrophin transcript specific to peripheral nerve. Nat Genet (1993) 1.53

Localization of DNA sequences in region Xp21 of the human X chromosome: search for molecular markers close to the Duchenne muscular dystrophy locus. Am J Hum Genet (1985) 1.52

Mapping a gene for congenital fibrosis of the extraocular muscles to the centromeric region of chromosome 12. Nat Genet (1994) 1.51

Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects. Kidney Int (2006) 1.50

On the relationship between human all-cause mortality and age. Eur J Epidemiol (2003) 1.49

Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion. J Biol Chem (1999) 1.48

The dystrophin associated protein complex in zebrafish. Hum Mol Genet (2003) 1.48

Skewed X inactivation in a female MZ twin results in Duchenne muscular dystrophy. Am J Hum Genet (1990) 1.48

A reversible structural interconversion involving [M(H2pdc)2(H2O)2] . 2H2O (M = Mn, Fe, Co, Ni, Zn, H3pdc = 3,5-pyrazoledicarboxylic acid) and the role of a reactive intermediate [Co(H2pdc)2]. Chemistry (2001) 1.47

Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity. J Cell Sci (2001) 1.46